Collegium Pharmaceutical, Inc. ( COLL) - Key Metrics
COLL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $6.48 | $0.54 | $3.88 | $3.86 |
| 2025Q3 | $6.63 | $1 | $2.48 | $2.48 |
| 2025Q2 | $5.91 | $0.38 | $2.28 | $2.28 |
| 2025Q1 | $5.59 | $0.08 | $1.74 | $1.72 |
COLL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 21.64 |
| 2025Q3 | ? | 8.77 |
| 2025Q2 | ? | 19.62 |
| 2025Q1 | ? | 98.16 |
COLL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 5.36% | ? |
| 2025Q4 | 8.34% | ? |
| 2025Q3 | 7.08% | ? |
| 2025Q2 | 7.69% | ? |
| 2025Q1 | 5.75% | ? |
COLL
Price: $33.38
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.06 USD
P/E Ratio: 17.38
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 465500
Ebitda: -13.3 millionMarket Capitalization: 1.2 billion